Literature DB >> 16942799

Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease.

Haydn N Allbutt1, Jasmine M Henderson.   

Abstract

Batteries of behavioural tests provide a method by which researchers may examine specific functional pathways. The narrow beam test examines the ability of a rat to cross a narrow, elevated beam of wood or other material. In order to determine the utility of the narrow beam test in the study of Parkinsonism, it was of interest to characterise the performance of animals at this task. Rats were placed at one end of a 105 cm long, elevated beam and both the time it took to begin crossing the beam, as well as the total time taken to cross the beam, were measured. The effects of training, time of day and 6-hydroxydopamine lesion on beam performance were examined. Rats reached maximal performance at the task within a single test session and time of day had no effect on beam performance. Parkinsonian rats demonstrated a four-fold increase in both the latency to initiate the task and the total time to cross the beam (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16942799     DOI: 10.1016/j.jneumeth.2006.07.006

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  29 in total

1.  Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease.

Authors:  Harpreet Kaur; Shaveta Chauhan; Rajat Sandhir
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

2.  5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

Authors:  Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch; Twum A Ansah
Journal:  Neuropharmacology       Date:  2010-03-31       Impact factor: 5.250

3.  Optogenetically stimulating intact rat corticospinal tract post-stroke restores motor control through regionalized functional circuit formation.

Authors:  A S Wahl; U Büchler; A Brändli; B Brattoli; S Musall; H Kasper; B V Ineichen; F Helmchen; B Ommer; M E Schwab
Journal:  Nat Commun       Date:  2017-10-30       Impact factor: 14.919

4.  KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity.

Authors:  Luis Arturo Fonseca-Fonseca; Yanier Nuñez-Figueredo; Jeney Ramírez Sánchez; Maylin Wong Guerra; Estael Ochoa-Rodríguez; Yamila Verdecia-Reyes; René Delgado Hernádez; Noelio J Menezes-Filho; Teresa Cristina Silva Costa; Wagno Alcântara de Santana; Joana L Oliveira; Juan Segura-Aguilar; Victor Diogenes Amaral da Silva; Silva Lima Costa
Journal:  Neurotox Res       Date:  2018-01-02       Impact factor: 3.911

5.  Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling.

Authors:  Tao Wang; Yan-yong Liu; Xin Wang; Nan Yang; Hai-bo Zhu; Ping-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2010-06-28       Impact factor: 6.150

6.  Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.

Authors:  Mohd Moshahid Khan; Syed Shadab Raza; Hayate Javed; Ajmal Ahmad; Andleeb Khan; Farah Islam; Mohammed M Safhi; Fakhrul Islam
Journal:  Neurotox Res       Date:  2011-12-23       Impact factor: 3.911

7.  Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease.

Authors:  Márcio Ferreira Dutra; Mariane Jaeger; Jocemar Ilha; Pedro Ivo Kalil-Gaspar; Simone Marcuzzo; Matilde Achaval
Journal:  Neurol Sci       Date:  2012-01-10       Impact factor: 3.307

8.  Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Zahra Kiasalari; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

9.  Perillyl Alcohol Mitigates Behavioural Changes and Limits Cell Death and Mitochondrial Changes in Unilateral 6-OHDA Lesion Model of Parkinson's Disease Through Alleviation of Oxidative Stress.

Authors:  Ehraz Anis; Mohd Faraz Zafeer; Fakiha Firdaus; Shireen Naaz Islam; Azka Anees Khan; M Mobarak Hossain
Journal:  Neurotox Res       Date:  2020-05-11       Impact factor: 3.911

10.  Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.

Authors:  Zahra Kiasalari; Mohsen Khalili; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Neurochem Res       Date:  2015-12-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.